BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27846885)

  • 1. Autophagy is associated with chemoresistance in neuroblastoma.
    Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
    Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.
    Gao J; Wang W
    Chem Biol Interact; 2019 Jan; 297():50-56. PubMed ID: 30365942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
    Wang L; Zhang H; Sun M; Yin Z; Qian J
    Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a inhibits progression of neuroblastoma by targeting autophagy-related gene 5.
    Cheng X; Xu Q; Zhang Y; Shen M; Zhang S; Mao F; Li B; Yan X; Shi Z; Wang L; Sheng G; Zhang Q
    Eur J Pharmacol; 2019 May; 850():53-63. PubMed ID: 30716314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
    Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
    J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
    Sartelet H; Imbriglio T; Nyalendo C; Haddad E; Annabi B; Duval M; Fetni R; Victor K; Alexendrov L; Sinnett D; Fabre M; Vassal G
    Histopathology; 2012 Jun; 60(7):1144-55. PubMed ID: 22394107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas.
    Katagiri H; Nakayama K; Razia S; Nakamura K; Sato E; Ishibashi T; Ishikawa M; Iida K; Ishikawa N; Otsuki Y; Nakayama S; Kyo S
    Int J Oncol; 2015 Dec; 47(6):2037-44. PubMed ID: 26458502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.
    Grimaldi M; Bo VD; Ferrari B; Roda E; De Luca F; Veneroni P; Barni S; Verri M; De Pascali SA; Fanizzi FP; Bernocchi G; Bottone MG
    Toxicol Appl Pharmacol; 2019 Feb; 364():1-11. PubMed ID: 30529627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy.
    Ognibene M; Podestà M; Garaventa A; Pezzolo A
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133 expression and MYCN amplification induce chemoresistance and reduce average survival time in pediatric neuroblastoma.
    Zhong ZY; Shi BJ; Zhou H; Wang WB
    J Int Med Res; 2018 Mar; 46(3):1209-1220. PubMed ID: 29322842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy.
    Cai Q; Wang S; Jin L; Weng M; Zhou D; Wang J; Tang Z; Quan Z
    Mol Cancer; 2019 Apr; 18(1):82. PubMed ID: 30953511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
    Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
    In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
    Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
    Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
    Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
    Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
    Wang Z; Lei H; Sun Q
    Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.
    Salm F; Cwiek P; Ghosal A; Lucia Buccarello A; Largey F; Wotzkow C; Höland K; Styp-Rekowska B; Djonov V; Zlobec I; Bodmer N; Gross N; Westermann F; Schäfer SC; Arcaro A
    Oncogene; 2013 Aug; 32(34):3944-53. PubMed ID: 23027129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
    Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
    Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.